Alan Mateo

This profile gathers the share dealings of Alan Mateo across 2 companies, led by Veeva Systems Inc and 10x Genomics, Inc. In total, 34 filings cover trades dated from 13 January 2016 to 4 June 2026.

Both buying and selling appear: 1 purchase worth €424k, against 4 sales worth €987k. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants and 26 option exercises.

The record was last updated on 8 June 2026 with a share grant in 10x Genomics, Inc. The last insider purchase was made public on 25 February 2025, 600 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.